XML 66 R24.htm IDEA: XBRL DOCUMENT v2.3.0.15
Segment Information
9 Months Ended
Sep. 30, 2011
Segment Information [Abstract] 
Segment Information

Note 17—Segment Information

The Company currently operates within one "Specialty Pharmaceutical" segment which includes sales of KRYSTEXXA, Oxandrin and oxandrolone and the research and development activities of KRYSTEXXA.